Auditory sensory memory and the cholinergic system:: Implications for Alzheimer's disease

被引:74
|
作者
Pekkonen, E [1 ]
Hirvonen, J
Jääskeläinen, IP
Kaakkola, S
Huttunen, J
机构
[1] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland
[2] Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, SF-00100 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, BioMag Lab, Med Engn Ctr, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Dept Clin Neurophysiol, Helsinki, Finland
基金
芬兰科学院;
关键词
D O I
10.1006/nimg.2001.0805
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Auditory sensory memory represents one of the simplest types of short-term memory that can be studied electrophysiologically with mismatch negativity (MMN); a specific auditory event-related potential indexing automatic comparison of incoming stimuli to an existing memory trace. Previous results suggest that auditory sensory memory deteriorates in aging and especially Mi Alzheimer's disease (AD). It has remained unsettled, however, whether MMN is regulated by the cholinergic system, which is deteriorated in AD contributing to cognitive impairments. We recorded cortical auditory responses with a magnetometer from 13 healthy subjects after intravenous injection of scopolamine, centrally acting cholinergic antagonist, or glycopyrrolate, a drug with a peripheral anticholinergic properties without penetrating the blood-brain barrier, using a double-blind protocol. Scopolamine reduced MMNm amplitude in response to frequency, but not duration, change, increased P50m amplitude, and delayed N100m latency. These findings suggest that the cholinergic system regulates the frequency-specific comparison of incoming stimuli to existing memory trace and modulates the preattentive processing related to stimulus detection. Further, neural mechanisms responsible for cortical frequency- and duration-specific discrimination appear to have different sensitivities to cholinergic modulation. Auditory evoked potentials might be suitable to monitor cholinergic activity in AD. (C) 2001 Academic Press.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 50 条
  • [31] The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
    R. Schliebs
    T. Arendt
    Journal of Neural Transmission, 2006, 113 : 1625 - 1644
  • [32] The glutamatergic system and Alzheimer's disease - Therapeutic implications
    Butterfield, DA
    Pocernich, CB
    CNS DRUGS, 2003, 17 (09) : 641 - 652
  • [33] ALZHEIMER-DISEASE, ATTENTION, AND THE CHOLINERGIC SYSTEM
    LAWRENCE, AD
    SAHAKIAN, BJ
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1995, 9 : 43 - 49
  • [34] Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease
    Rattray, M
    BIOLOGICAL PSYCHIATRY, 2001, 49 (03) : 185 - 193
  • [35] Nicotinic cholinergic intercellular communication: Implications for the developing auditory system
    Morley, BJ
    HEARING RESEARCH, 2005, 206 (1-2) : 74 - 88
  • [36] Reimagining cholinergic therapy for Alzheimer's disease
    Giacobini, Ezio
    Cuello, A. Claudio
    Fisher, Abraham
    BRAIN, 2022, 145 (07) : 2250 - 2275
  • [37] Role of Cholinergic Signaling in Alzheimer's Disease
    Chen, Zhi-Ru
    Huang, Jia-Bao
    Yang, Shu-Long
    Hong, Fen-Fang
    MOLECULES, 2022, 27 (06):
  • [38] Magnesium and Alzheimer's Disease: The Cholinergic Hypothesis
    Heinitz, Matthias F.
    SCHWEIZERISCHE ZEITSCHRIFT FUER GANZHEITSMEDIZIN, 2012, 24 (06): : 371 - 374
  • [39] Cholinergic foundations of Alzheimer's disease therapy
    Giacobini, E
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 : 1 - 1
  • [40] Revisiting the cholinergic in the development of Alzheimer's disease
    Craig, Laura A.
    Hong, Nancy S.
    McDonald, Robert J.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2011, 35 (06): : 1397 - 1409